126 related articles for article (PubMed ID: 16684565)
1. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
Roy S; Banerjee R; Sarkar M
J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
Chakraborty S; Bose M; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
[TBL] [Abstract][Full Text] [Related]
3. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.
Chakraborty S; Sehanobish E; Sarkar M
J Biol Inorg Chem; 2012 Mar; 17(3):475-87. PubMed ID: 22270943
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic studies on the interaction of DNA with the copper complexes of NSAIDs lornoxicam and isoxicam.
Goswami S; Ray S; Sarkar M
Int J Biol Macromol; 2016 Dec; 93(Pt A):47-56. PubMed ID: 27554932
[TBL] [Abstract][Full Text] [Related]
5. Modulation of non steroidal anti-inflammatory drug induced membrane fusion by copper coordination of these drugs: anchoring effect.
Majumdar A; Chakraborty S; Sarkar M
J Phys Chem B; 2014 Dec; 118(48):13785-99. PubMed ID: 25380501
[TBL] [Abstract][Full Text] [Related]
6. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
Cini R; Tamasi G; Defazio S; Hursthouse MB
J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
[TBL] [Abstract][Full Text] [Related]
7. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
Chakraborty H; Roy S; Sarkar M
Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
[TBL] [Abstract][Full Text] [Related]
8. Interaction of copper(II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: synthesis, structure, DNA- and albumin-binding.
Dimiza F; Perdih F; Tangoulis V; Turel I; Kessissoglou DP; Psomas G
J Inorg Biochem; 2011 Mar; 105(3):476-89. PubMed ID: 20926136
[TBL] [Abstract][Full Text] [Related]
9. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
Banerjee R; Chakraborty H; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
[TBL] [Abstract][Full Text] [Related]
10. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
[TBL] [Abstract][Full Text] [Related]
11. Interaction of a common painkiller piroxicam and copper-piroxicam with chromatin causes structural alterations accompanied by modulation at the epigenomic/genomic level.
Goswami S; Sanyal S; Chakraborty P; Das C; Sarkar M
Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):2048-2059. PubMed ID: 28411076
[TBL] [Abstract][Full Text] [Related]
12. Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
Tamasi G; Serinelli F; Consumi M; Magnani A; Casolaro M; Cini R
J Inorg Biochem; 2008 Oct; 102(10):1862-73. PubMed ID: 18667239
[TBL] [Abstract][Full Text] [Related]
13. Small Mismatches in Fatty Acyl Tail Lengths Can Effect Non Steroidal Anti-Inflammatory Drug Induced Membrane Fusion.
Majumdar A; Sarkar M
J Phys Chem B; 2016 Jun; 120(21):4791-802. PubMed ID: 27153337
[TBL] [Abstract][Full Text] [Related]
14. Interactions of human serum albumin with meloxicam: characterization of binding site.
Trynda-Lemiesz L; Wiglusz K
J Pharm Biomed Anal; 2010 Jun; 52(2):300-4. PubMed ID: 20089378
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
Chakraborty H; Banerjee R; Sarkar M
Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
[TBL] [Abstract][Full Text] [Related]
16. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
Mondal Roy S; Sarkar M
Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drug induced membrane fusion: concentration and temperature effects.
Mondal S; Sarkar M
J Phys Chem B; 2009 Dec; 113(51):16323-31. PubMed ID: 19954169
[TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
[TBL] [Abstract][Full Text] [Related]
19. Host-guest complexation of oxicam NSAIDs with beta-cyclodextrin.
Banerjee R; Chakraborty H; Sarkar M
Biopolymers; 2004 Nov; 75(4):355-65. PubMed ID: 15372483
[TBL] [Abstract][Full Text] [Related]
20. The reactions of oxicam and sulfoanilide non steroidal anti-inflammatory drugs with hypochlorous acid: determination of the rate constants with an assay based on the competition with para-aminobenzoic acid chlorination and identification of some oxidation products.
Van Antwerpen P; Dubois J; Gelbcke M; Neve J
Free Radic Res; 2004 Mar; 38(3):251-8. PubMed ID: 15129733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
